Soluble type immune checkpoint regulators using multiplex luminex immunoassay in chronic hepatitis B patients

Abstract

Our results showed the preliminary data on dysregulated sICs in patients with CHB that may have clinical significance in diagnosis of patients with CHB. It can be applied to develop therapeutic target of HBV infection.